University of California, Los Angeles
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of California, Los Angeles sits in the top decile of US sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count).
University of California, Los Angeles: 897 sponsored US clinical trials, 158 recruiting.
University of California, Los Angeles sponsors 897 registered US clinical trials on ClinicalTrials.gov, 158 of them currently recruiting, and 622 completed. 98 of these trials are in Phase 3-4 (later-stage) and 194 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 17 trials.
Top-decile sponsor footprint
University of California, Los Angeles ranks in the top decile of sponsors by registered trial count (#37 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
622 of 679 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (91.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
897 total, page 9 of 18
Effect of Pomegranate Juice Consumption on the Health of Mothers and Infants During Breastfeeding
NCT04341961
Adolescent Cancer Telemedicine for Pain Management
NCT03603886
Improving the Diagnosis of Common Variable Immune Deficiency
NCT03335605
Quadratus Lumborum Nerve Blocks for Myomectomies
NCT03935815
Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF)
NCT03251144
Comparing Preoperative Injection of Mitomycin-C vs. Intraoperative Injection of Mitomycin-C vs. Topical Application of Mitomycin-C (Conventional Use) in Trabeculectomy
NCT03875911
Shared Decision Making in Diabetes Prevention for Women With a History of GDM
NCT03766256
IPACK and Adductor Canal Catheter Patient Outcomes for TKAs?
NCT03774966
ECigs, Inflammation and Oxidative Stress
NCT03823885
The Effects of Manipulating Expectations in a Gratitude Intervention
NCT03784001
Investigation of PJ vs. Sugar on Glucose Levels in Healthy and Prediabetic Subjects
NCT04591782
Transcranial Magnetic Stimulation and Tobacco Use Disorder
NCT03827265
Treatment for Affect Dimensions
NCT03439748
The Safety and Intake Rate of a Natural Compound Arctigenin in Healthy Men
NCT03703388
The Cardiovascular Effects of Electronic Hookah Vaping
NCT03690427
Sleep Without Insomnia or The Use of Chronic Hypnotics
NCT03687086
High Frequency Oscillation in Pediatric Epilepsy Surgery
NCT03790280
Technology Enhanced Family Treatment
NCT03913013
Deep Brain Stimulation with LIFUP for Mild Cognitive Impairment and Mild Alzheimer's Disease
NCT03347084
Randomized Controlled Trial of Standard ERP and OC-Go
NCT03601312
Postpartum Care Timing: A Randomized Trial
NCT03733405
Optimizing Exposure Therapy With Mental Rehearsal
NCT03934385
Guided Meditation and Stress-Induced Eating
NCT03707197
Patient Portal - Flu Reminder Recall
NCT03666026
Treating Phobia With Multivoxel Neuro-reinforcement
NCT03655262
Ibudilast for the Treatment of Alcohol Use Disorder
NCT03594435
A Clinical Decision Support Trial to Reduce Intraoperative Hypotension
NCT04062994
Transcranial Direct Current Stimulation as a Neuroprotection in Acute Stroke
NCT03574038
Effect of Strawberry Consumption on the Microbiome
NCT04217122
A Dyadic Sleep Intervention for Alzheimer's Disease Patients and Their Caregivers
NCT03455569
Cefixime for Alternative Syphilis Treatment
NCT03660488
Leucine for Depression Study (L-DEP)
NCT03557684
MyLife: A Digital Health Coaching Program
NCT03529903
The STOP-HPV Trial 2: Performance Feedback Intervention
NCT03599570
The STOP-HPV Trial 1: Communication Intervention
NCT03599557
Ibudilast and Withdrawal-Related Dysphoria
NCT03489850
Mindfulness Meditation and Insomnia in Alzheimer Disease Caregivers
NCT03538574
SMART Program in Irritable Bowel Syndrome (IBS)
NCT03454386
Brief Intervention by Community Health Workers for Unhealthy Drinking in Latinos
NCT03301064
Heterogeneity in ASD: Biological Mechanisms, Trajectories, and Treatment Response
NCT03253081
N-Acetyl Cysteine Protects Pulpal Stem Cells in Endodontic Revascularization
NCT03451435
Pilot Test of Patient Decision Aid for Opioid Use Disorder
NCT03394261
Acupuncture vs TENS for Gag Reflex
NCT04757948
Reducing Risk for Alzheimer's Disease in High-Risk Women Through Yogic Meditation Training
NCT03503669
Comparative Effectiveness of System Interventions to Increase HPV Vaccine Receipt in FQHCs
NCT03726151
Platelet Function on Abacavir and Tenofovir
NCT03081572
Increasing Human Papillomavirus (HPV) Vaccine Uptake Via General Health Messaging
NCT03759236
Study: SONAS Ultrasound for Detecting Stroke SONAS Ultrasound for Detecting Stroke
NCT03296852
Effects of Phytonutrients on Vascular Health and Skin in Obese Males
NCT03496584
Laboratory-based Hypnosis Intervention on Pain Responsivity in Adolescents With Sickle Cell Disease
NCT02987725
What is open in the University of California, Los Angeles pipeline
158 recruiting of 897 indexed (18% open); 622 completed (69%).
Phase mix: 98 late (III/IV) vs 194 early (I/II) (early-phase heavy).
Top condition: Depression (17 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of California, Los Angeles: open-pipeline peers nationwide
Peers matched on 897 registered trials and 18% open enrollment, not the therapeutic-area sidebar.
University of California, Los Angeles sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 897 trials (± recruiting share)
- Indiana University · 890 trials · 18% recruiting
- Hoffmann-La Roche · 909 trials · 8% recruiting
- Brigham and Women's Hospital · 937 trials · 15% recruiting
- University of Texas Southwestern Medical Center · 837 trials · 19% recruiting
Sponsors near 18% open enrollment (± trial volume)
- ConvaTec · 18% recruiting · 17 trials
- Endologix · 18% recruiting · 17 trials
- National Institute on Deafness and Other Communication Disorders (NIDCD) · 18% recruiting · 34 trials
- NICHD Pelvic Floor Disorders Network · 18% recruiting · 17 trials
Related
What to do with this University of California, Los Angeles page
897 registered trials is a research-attention snapshot, not an endorsement of University of California, Los Angeles or any single study.
- 158 of University of California, Los Angeles's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Depression is the condition University of California, Los Angeles studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of California, Los Angeles pipeline card: 897 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.